The development of flurbiprofen–antioxidant mutual prodrugs combines effective anti-inflammatory properties with improved gastrointestinal safety. Using natural antioxidants as esterifying agents, the prodrugs temporarily mask the carboxylic acid group, mitigating direct gastric irritation. Upon hydrolysis in plasma, they release active flurbiprofen. These prodrugs demonstrated strong anti-inflammatory and analgesic effects, with reduced gastric toxicity in animal studies. Computational analyses confirmed selective COX-2 inhibition, supporting their potential as safer NSAIDs.
Ashraf, Z., Alamgeer, Kanwal, M., Hassan, M., Abdullah, S., Waheed, M., Ahsan, H., and Kim, S.J., 2016. Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling. Drug Des Devel Ther.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Flurbiprofen 50 by Swiss Remedies, consult with your doctor or healthcare professional.
Ashraf, Z., Alamgeer, Kanwal, M., Hassan, M., Abdullah, S., Waheed, M., Ahsan, H., and Kim, S.J., 2016. Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling. Drug Des Devel Ther.
Ashraf, Z., Alamgeer, Kanwal, M., Hassan, M., Abdullah, S., Waheed, M., Ahsan, H., and Kim, S.J., 2016. Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling. Drug Des Devel Ther.
Ashraf, Z., Alamgeer, Kanwal, M., Hassan, M., Abdullah, S., Waheed, M., Ahsan, H., and Kim, S.J., 2016. Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling. Drug Des Devel Ther.